Obstetric Anesthesia Experiences in COVID-19 Positive Patients

Sponsor
Turkiye Yuksek Ihtisas Education and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04691934
Collaborator
(none)
61
1
9.5
6.4

Study Details

Study Description

Brief Summary

At the end of 2019, a new coronavirus named COVID-19 (SARS-CoV-2), one of the lower respiratory tract samples was detected in China. The World Health Organization (WHO) declared it a global epidemic on March 11, 2020, due to the emergence of COVID-19 cases in 113 countries other than China, where the first epidemic occurred, and the spread and severity of the virus. Pregnancy increases susceptibility to respiratory complications of viral diseases.

This study aimed to retrospectively evaluate the demographic data of COVID-19 patients undergoing cesarean section, our anesthesia practices, complications, and condition of neonates, and to summarize up-to-date information on COVID-19 in obstetric anesthesia.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Anesthesia management

Detailed Description

Our study was a single-center, retrospective, and observational trial and carried out with the principles of the Declaration of Helsinki. All patient demographics and information about anesthesia were analyzed retrospectively from the patient files.

All patients were operated in negative pressure operating theatres reserved for them. The whole team was equipped with Level 3 personal protective equipment (PPE) (liquid-proof apron, N-95 mask, goggles, visor, overshoes). Anesthesia was administered by 2 healthcare professionals from the anesthesia team, including an experienced anesthesiologist and an assistant anesthesia technician. A third person was kept ready outside to help in case of need.

Study Design

Study Type:
Observational
Actual Enrollment :
61 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Our Anesthesia Experiences in COVID-19 Positive Patients Undergoing Cesarean Section: A Retrospective Single-center Cohort Study
Actual Study Start Date :
Mar 11, 2020
Actual Primary Completion Date :
Dec 25, 2020
Actual Study Completion Date :
Dec 25, 2020

Outcome Measures

Primary Outcome Measures

  1. obstetric anesthesia practices [until 30 minutes after arrival in the operating room]

    the type of anesthesia was investigated

Secondary Outcome Measures

  1. anesthesia complications [up to 1 hour after anesthesia]

    hypotension, nausea, vomiting, allergies

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients who underwent cesarean section

  • Patients who had positive PCR nasopharyngeal swabs for COVID-19

Exclusion Criteria:
  • Patients who tested negative and were clinically suspicious

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Health Sciences Turkey, Bursa Yuksek Ihtisas Training and Research Hospital Bursa Yıldırım Turkey 16290

Sponsors and Collaborators

  • Turkiye Yuksek Ihtisas Education and Research Hospital

Investigators

  • Principal Investigator: Derya Karasu, BursaYuksek Ihtisas Training and Research Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Derya Karasu, MD, Assoc Prof., Turkiye Yuksek Ihtisas Education and Research Hospital
ClinicalTrials.gov Identifier:
NCT04691934
Other Study ID Numbers:
  • U1111-1263-2201
First Posted:
Dec 31, 2020
Last Update Posted:
Dec 31, 2020
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Derya Karasu, MD, Assoc Prof., Turkiye Yuksek Ihtisas Education and Research Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 31, 2020